ASP-5854 is an adenosine A(2A) receptor antagonists that has therapeutic potential for the treatment of Parkinson's disease to ameliorate motor deficiencies. References: Mihara T, Iwashita A, Matsuoka N. A novel adenosine A(1) and A(2A) receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: comparison with existing anti-Parkinson's disease drugs. Behav Brain Res. 2008 Dec 12;194(2):152-61. doi: 10.1016/j.bbr.2008.06.035. Epub 2008 Jul 6. PubMed PMID: 18657577.

纯度：≥98%

CAS：851087-60-0